Clinical Trials Browser

Terminated × Salivary Gland Neoplasms × Trastuzumab × Clear all

NCT00126607 2013-02-28

Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Phase 2 Terminated

Salivary Gland Neoplasms